Favorable outcomes of patients with limited-stage ocular adnexal DLBCL treated in the rituximab era: Long-term follow-up of a single center experience Meeting Abstract
| Authors: | Qualls, D.; Batlevi, C. L.; Caron, P. C.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Khan, N.; Kumar, A.; Matasar, M. J.; Moskowitz, A. J.; Noy, A.; Owens, C.; Palomba, M. L.; Straus, D. J.; von Keudell, G.; Zelenetz, A. D.; Okwali, M.; Yahalom, J.; Schöder, H.; Dogan, A.; Salles, G.; Falchi, L. |
| Abstract Title: | Favorable outcomes of patients with limited-stage ocular adnexal DLBCL treated in the rituximab era: Long-term follow-up of a single center experience |
| Meeting Title: | 63rd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000835740102054 |
| DOI: | 10.1182/blood-2021-153171 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4578 -- Hybrid meeting, also took place online -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
